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ABSTRACT 
 
TO ELUCIDATE THE BENEFIT OF CONTINUOUS PERINEURAL 
CATHETERS OVER SINGLE SHOT PERIPHERAL NERVE BLOCKS 
ACCORDING TO PUBLISHED LITERATURE 
 
Aim and Objectives : 
 This study was performed to compare the efficacy of continuous peripheral 
nerve blocks over single shot peripheral nerve in upper limb orthopedic surgeries.  
 
Methods and materials  
 Sixty patients, ASA I and II were randomized into two groups, Group SS 
received single shot peripheral nerve block, Group CS received continuous peripheral 
nerve block. 
 Post-operative pain relief, Break through pain and Rescue Analgesia for the 
two groups were compared.  
 
Results : 
 The VAS Score in Group SS (6.27 + 1.08) and in Group CS (0.97 + 41), and 
both groups were compared. Break through pain and analgesia score in Group SS 
(4.53 + 0.53) compared with Group CS (0.53 + 0.73) and when p value was 
calculated, it was found to be statistically significant.  
 
Conclusion : 
 We have concluded that continuous peripheral nerve blocks provide better 
post-operative pain relief, less incidence of Break through pain and requirement of 
rescue analgesia is also reduced.  
Key words : C-PNB, S-PNB, Breakthrough Pain, Rescue Analgesia, Bupivacaine.  
INTRODUCTION 
 
 "C-PNB was first proposed by Anbro is 1946, It has crossed many leaps 
and strides starting from, tape attached to patient’s chest to many wide and 
more validated analgesic technique in the post-operative care unit1, The early 
period CPNB was done, to prolong the intra-operative surgical anaesthesia and 
the treatment of intractable hiccups. The indications for C-PNB has evolved 
since then and many indication have been found in literature, which includes 
wide range of treatment options from the vasospasm induced by Raynaud’s 
disease2; induction of sympathectomy and vasodilation for improvement of 
blood flow after vascular surgery, reimplantation or limp salvage treatment of 
deep vein thrombosis, analgesia in the setting of trauma, treatment of Chronic 
pain syndrome such as trigeminal neuralgia3, complex regional pain syndrome, 
terminal cancer pain, and phantom limb pain. Independently of these 
indications, the majority of publications dealing with CPNB do focus on pain 
treatment in post operative treatment where the validation of the theory that the 
regional anaesthesia and analgesia is superior then opioid based analgesia  
following major surgery, However post surgical pain is the only indication 
which is more validated using randomized controlled trails compared with 
opioid analgesia C-PNB provided better analgesia with less incidence of opiod 
induced side effects like nausea, vomiting, pruritis and sedation4, Cochrane 
review showed no impact of regional anaesthesia compared to general 
anaesthesia on mortality after hip fractures. Only the acute post operative 
confusion and delirium was found to reduced after regional anaesthesia, 
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However for continuous peripheral regional anaesthesia these findings cannot 
be extrapolated, Though continuous peripheral regional anaesthesia offers 
improved functional outcomes after extremity surgeries atleast for a short 
period upto 6 months5,6,7"".  
 
 "Despite these evidence of value, the hypothesis that regional anaethesia 
has an overall beneficial and long lasting effect on patient outcome following 
surgery still remain difficult to prove and has been challenged, especially in 
times with reduced resources, For more than 30 years regional anaesthesia has 
challenged anaesthesiologist to determine whether it offers real benefits over 
other types of anaesthesia, such as preserving cognitive function after major 
surgery compared to general anaesthesia, improving long term joint function 
and rehabilitation leading to earlier return to work, reducing costs, reducing the 
need for blood transfusions and increasing patient – reported outcomes such as 
satisfaction, quality of life and quality of recovery, This study will compare the 
benefits of C-PNB over single – shot perineural blocks according to published 
literature".  
 
Historical Technical Development in Peripheral Nerve Blockades. 
During the times of progress in medicine, the discovers of new 
techniques and pharmacological development of the vibrant 19th century, it was 
Sir Francis Rynd who performed the first documented nerve block with 
morphine in 1845, Alexander wood followed this example with better 
equipment, consisting of a syringe and a needle, to inject morphine close to the 
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nerves in 1855. In the same period, cocaine, derived from the leaves of 
Erythroxylon coxa was introduced into clinical practice for its systemic effects. 
Karl koller, a Viennese ophthalmologist, searched for agents with local 
insensibility capacities for eye surgery, and by chance he found the Cocaine. 
Experiments with cocaine followed successfully, after which Koller’s instilled 
cocaine to the eye of patients for local anesthesia prior to surgery. The 
preliminary  results of Koller’s clinical trial with cocaine were presented during 
a meeting of opthalmogist in Heidelberg (1884) In the same year. William 
S.Halsted, surgeon in New York. Experiment with cocaine after reading 
Kollers report and performed the first axillary nerve block by injecting cocaine 
under direct vision near the nerves. Later other local anaesthetics were 
developed, Because of the addictives and toxic side effects of cocaine. Hirshel 
and Kuhlenkampff refined the technique to a precutaneous of unpresented 
approaches and new nerve block techniques often associated with incomplete 
anesthesia and unexpected failures or complications. In contrast to general 
anesthesia become less popular due to moderate success rate. The site of needle 
insertion was defined upon the basis of external anatomical landmarks and 
eliciting paraesthesia of the nerve with the needle subsequently localizes the 
nerve. Although Perthes had already described the electrical nerve stimulation 
in 1912, it took half a century before an electrical stimulator suitable for 
clinical applications in localizing a nerve was available, Using this method 
corresponding motor contractions are elicited by electrical stimulation when 
needle is advanced into the vicinity of the nerve or neural plexus. The current 
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of the nerve stimulator should be reduced to the threshold at which minimal 
motor responses are still observed. The quantity of the threshold would be 
proportional to distance between the needle tip and nerve according to the law 
of coulomb.AS minimum of 0.3-0.5mA was advised as a safe and effective 
threshold standard needles were soon replaced by specially designed needles 
with isolated shaft and blunt tip. This method was believed to contribute to 
patient safety by reducing the risk of nerve damage, which, however has never 
been proved. Although the axillary block was the most commonly used 
technique for anaesthesia of the upper limb, even with guidance by an electrical 
nerve stimulator, the success rates were still around 80-90% on the basis of 
anatomical landmark, in 2002 a percutaneous variant of the invasive nerve 
stimulation technique was developed. This technique was for pre-locating the 
nerve by indenting the skin with an electrical stimulation pen to elicit 
accompanying motor and sensory response. The stimulation pen was believed 
to assist in determining the optimal puncture site for superficial nerve electrical 
stimulation pen in a value nerve stimulates remains evident and this technique 
is often used in combination with ultrasound to identify the nerves with more 
safety and reliability. Nerve stimulation provides functional information to the 
inexperienced users of ultra sonography in addition to the ultrasonography 
images of the targeted nerves.    
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ANATOMY17 
 
An understanding of regional anesthesia anatomy and technique is 
required for the present day anesthesiologist, for their practice, although 
anatomic relationships have not changed over time, our ability to identify them 
has evolved. From the paraesthesia – seeking techniques described by Winnie 
in the mid – twentieth century, to the popularization of the nerve stimulator, to 
the introduction of ultrasound guidance, anesthesiologists and their patients 
have benefitted from technology’s evolution. The field of regional anesthesia 
has accordingly expanded to one that addresses not only the intra operative 
concerns of the anesthesiologist, but also longer term peri-operative pain 
management.  
 
 In addition to potent analgesia, regional anesthesia may lead to 
reductions in the stress response, systemic analgesic requirements, opioid – 
related side effects, general anesthesia requirements, and possibly the 
development of chronic pain.  
 
Patient Selection :  
 The Selection of a regional anesthetic technique is a process that begins 
with a thorough history and physical examination. Although many patients are 
candidates for regional anesthesia / analgesia, as with any medical procedure a 
risk – benefit analysis must be performed. The risk – benefit ratio often favors 
regional anesthesia in patients with multiple comorbidities for whom a general 
anesthetic carries a greater risk. In addition, patients intolerant to systemic 
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analgesics (eg. those with obstructive sleep apnea or at high risk for nausea) 
may benefit from the opioid – sparing effects of a regional analgesic. Patients 
with chronic pain and opioid tolerance may receive optimal analgesia with a 
continuous peripheral nerve block (so called perinueral local anesthetic 
infusion).  
 
 A comprehensive knowledge of anatomy and an understanding of the 
planned surgical procedure are important for selection of the appropriate 
regional anesthetic technique. If possible, discussion with the surgeon about 
various considerations (tourniquet placement, bone grafting, projected surgical 
duration) is ideal. Also, knowing the anticipated course of recovery and 
anticipated level of postoperative pain will often influence specific decisions 
regarding a regional anesthetic technique (eg. a single injection versus 
continuous peripheral nerve block).  
 
Nerve Stimulation Technique 
For this technique, an insulated needle tip, while a wire attached to the 
needle hub connect to a nerve stimulator-a battery-power machine that emits a 
small amount (0-5 mA) of electric current at a set interval (usually 1 or 2 Hz). 
A grounding electrode is attached to the patient to complete the circuit. When 
the insulated needle is placed in proximity to a motor nerve, muscle 
concentrations are induced, and local anesthetic is injected. Although it is 
common to redirect the block needle until muscle contractions occur at a 
current less than 0.5 mA, there is scant evidence to support this specific current 
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in all cases. Similarly, although some have suggested that muscle contraction 
with current less than 0.2 to 0.5 mA implies intraneural needle placement, there 
is little evidence to support this specific cutoff. Nonetheless, most practitioners 
inject local anesthetic, when current between 0.2 mA results in a muscle 
response. For most blocks using this technique, 30-40mL of anesthetic is 
usually injected with gentle aspiration between divided doses.     
 
 
 
 
 
 
 
 
 
Fig.1 A nerve stimulator delivers a small amount of electric current to the 
block needle to facilitate nerve localization.  
 
Continuous Peripheral Nerve Blocks  
Also termed perineural local anesthetic infusion, continuous nerve 
blocks involve the placement of a percutaneous catheter adjacent to a 
peripheral nerve, followed by local anesthetic administration to prolong a 
nerve block.  Potential advantages appear to depend on successfully 
improving analgesia and dynamic pain, supplemental analgesic requirements, 
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opioid - related side effects, and sleep  disturbances. In some cases patient 
satisfaction, ambulation, and functioning may be improved; an accelerated 
resumption of passive joint range-of-motion realized; and reduced time until 
discharge –readiiness  as well as actual discharge from the hospital or 
rehabilitation center  achieved    There are many types of  catheters, including 
nonstimulating and stimulating, flexible and more rigid, through-the-needle 
and over-the-needle. Currently, there is little evidence that a single design 
results in superior effects. Local anesthetic is the primary medication infused, 
as adjuvants do not add benefits to perineural infusions (unlike single-
injection peripheral nerve blocks). The recent evidence suggests that it is the 
total dose, and not concentration, that determines the majority of block 
effects. Unlike single-injection peripheral nerve blocks, no adjuvant added to 
a perineural local anesthetic infusion has been demonstrated to be of benefit. 
The local anesthetic may be administered exclusively as repeated bolus doses 
or a basal infusion, or as a combination of the two methods. Using a small, 
portable infusion pump, continuous peripheral nerve blocks may be provided 
on an ambulatory basis. 
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Fig.2.  Placement of a percutaneous catheter adjacent to a peripheral nerve. 
 
As with all medical procedures, they are potential risks associated with 
continuous peripheral nerve blocks. Therefore, these infusions are usually 
reserved for patients having procedures expected to result in postoperative pain 
that is difficult to control with oral analgesics and will not resolve in less time 
than the duration of single injection peripheral nerve block. Serious 
complications, which are relatively rare, include systemic local anesthetic 
toxicity, catheter rejection, nerve injury, infection, and retroperitoneal 
hematoma formation. In addition, a perineural infusion affecting the femoral 
nerve increases the risk of falling, although to what degree and by what specific 
mechanism (eg. sensory, motor, or proprioception deficits) remains unknown. 
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Supraclavicular Block : 
 Once described as the “spinal of the arm”, a supraclavicular block offers 
dense anesthesia of the brachial plexus for surgical procedures at or distal to 
the elbow (figure). Historically, the supraclavicular block fell out of favor due 
to the high incidence of complications (namely, pneumothorax) that occurred 
with paresthesia and nerve stimulator techniques. It has seen a resurgence in 
recent years as the use of ultrasound guidance has theoretically improved 
safety. The supraclavicular block does not reliably anesthetize the axillary and 
supravascular nerves, and thus is not ideal for shoulder surgery. Sparing of 
distal branches, particularly the Ulnar nerve, may occur. Supraclavicular 
perineural catheters provide inferior analgesia compared with infraclavicular 
infusion and are often displaced due to a lack of muscle mass to aid catheter 
retention.  
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Fig.3 Supraclavicular block can provide dense anesthesia for procedures at 
or distal to the elbow. Light blue shading indicates regions of variable 
blockade; purple shading indicates regions of more reliable blockade.  
 
Many of the same precautions that are taken with patient selection for an 
interscalene block should be exercised with a supraclavicular block. Nearly 
half of patients undergoing supraclavicular block will experience ipsilateral 
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phernic nerve palsy, although this incidence may be decreased by using 
ultrasound ultrasound guidance, allowing use of a minimal volume of local 
anesthetic. Horner’s syndrome and recurrent laryngeal nerve palsy may also 
occur. Pneumothorax and subclavian artery puncture, although theoretically 
less likely under ultrasound guidance, remain potential risks.  
 
Axillary Block : 
  At the lateral border of the pectorails minor muscle, the cords of the 
branchial plexus form large terminal branches. The axillary, musculoctaneous, 
and medial brachial cutaneous nerves branch from the brachial plexus proximal 
to the location in which local anesthetic is deposited during an axillary nerve 
block, and thus are usually spared. At this level, the major terminal nerves 
often are separated by fascia, therefore multiple; injections (10-mL each) may 
be required to reliably produce anesthesia of the entire arm distal to the elbow.  
 
 There are few contraindications to axillary brachial plexus blocks. Local 
infection, neuropathy, and bleeding risk must be considered. Because the axilla 
is highly vascularized, there is a risk of local anesthetic uptake through small 
veins traumatized by needle placement. The axilla is also a suboptimal site for 
perineural catheter placement because of greatly inferior analgesia versus an 
infraclavicular infusion, as well as theoretically increased risks of infection and 
catheter dislodgement.  
 
 All of the numerous axillary block techniques require the patient to be 
positioned supine, with the arm abducted 900 and the head turned toward the 
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contralateral side. The axillary artery pulse should be palpated and its location 
marked as a reference point.  
 
A. Transarterial Technique : 
 This technique has fallen out of favour due to the trauma of twice 
purposefully penetrating the axillary artery along with a theoretically increased 
risk   of inadvertent intravascular local anesthetic injection. The nondomiant 
hand is used to palpate and immobilize the axillary artery, and a 22-aguaue 
needle is inserted high in the axilla until bright red blood is aspirated. The 
needle is then slightly advanced until blood aspiration ceases. Injection can be 
performed posteriorly, anteriorly, or both locations in relation to the artery. A 
total of 30 – 40 mL of local anesthetic is typically used.  
 
B. Nerve Stimulation  
 Again the non-dominant hand is used to palpate and immobilize the 
axillary artery. With the arm abducted and externally rotated, the terminal 
nerves usually lie in the following positions relative to the artery, (Fig. 
although variations are common): median nerve superior (wrist flexion, thumb 
opposition, forearm pronation); ulnar nerve inferior (wrist flexion, thumb 
adduction, fourth / fifth digit flexion); and radial nerve inferior – posterior 
(digit / wrist / elbow extension, forearm supination). The musculocutaneous 
nerve (elbow flexion) is separate and deep within the coracobrachials muscle, 
which is more superior (lateral) in this position and, as a consequence, is often 
not blocked with this procedure (Fig. ). A 2-in., 22-guage insulated needle is 
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inserted proximal to the palpating fingers to elicit muscle twitches in the hand. 
Once an acceptable muscle response is identified, and after reducing the 
stimulation to less than 0.5 mA, careful aspiration is performed and local 
anesthetic is injected. Although a single injection of 40 mL may be used, 
greater success will be seen with multiple nerve stimulations (ie, two or three 
nerves and divided doses of local anesthetic.  
 
 
   
 
 
 
 
 
 
 
 
Fig.4. Axillary Block. The axillary, musculocutaneous and medial brachial 
cutaneous nerves are usually spared with an axillary approach.  
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Fig 5. A : Patient positioning and needle angle for axillary brachial plexus 
block.  
Fig 5. B : A multiple technique is more effective because of fascial separation 
between nerves.  
 
 
 
 
 
 
 
 
 
 
Fig.6.  Positioning of terminal nerves about the axillary artery (variations are 
common). 
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1. Nerve Stimulation :  
 With the patient positioned supine, a line is drawn along the inguinal 
ligament, from the anterior superior iliac spine to the public tubercle. A second 
line is drawn parallel to the first that traverses the greater trochanter 
(intertrochanteric line). Next, these two lines are connected with a third line 
drawn from the point between the medial one third and lateral two thirds of the 
first line, at 900 angle, and extended caudally to intersect with the 
intertrochanteric line. A long (10 to 15 cm needle is inserted through this 
intersection and directly posterior until foot inversion of plantarflexion is 
elicited (dorsiflexion is acceptable for postoperative analgesia). Often with this 
approach, the femur is conducted before the needle reaches the sciatic nerve. 
When this occurs, the needle should be withdrawn 2 – 3 cm, the patient should 
be asked to internally rotate the leg, and then the needle should be advanced. If 
the femur is contacted again, the landmarks may require reassessment. A local 
anesthetic volume of 25 mL provides surgical anesthesia.  
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PHYSIOLOGY OF PAIN18 
 
Pain was called by Sherrington, “The physical adjunct of a imperative 
protective reflex to painful stimuli which generally initiate potent withdrawals 
and avoidance response”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7. Illustration of Pain Pathway  
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 Fig 8.Types of Pain Pathway  
 
Pain is defined by the international association of study of pain “an 
unpleasant sensory and emotional experience associated with actual or 
potential tissue damage or described in terms of such damage. 
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Pain is classified as fast and slow a painful stimuli causes bright sharp 
localized sensation (fast pain) followed by dull intense, diffuse, and unpleasant 
feeling (slow pain) evidence suggest that fast pain is due to activity in AD 
fibers, where as slow pain is due to the activity in the C fibers. 
 
         Physiological or actuate pain 
                                     Pathological pain or chronic pain  
 
Acute pain typically has a sudden onset and recedes during healing 
process. Acute pain can be considered as good pain as it serves an important 
protective mechanism. Chronic pain can be considered as bad pain because it 
persists long after recovery from injury and is often refractory to common 
analgesic agents including non-steroidal anti inflammatory drugs and opiates 
chronic pain can result from nerve injury (neuropathic pain) including diabetic 
neuropathy, toxin induced nerve damage, and ischemia. 
 
Deep pain: 
       The main difference between superficial and deep sensitivity is the 
different nature of pain evoked by noxious stimuli. This probably due to a 
relative deficiency of act nerve fibers in deep structures, so there is little rapid, 
bright pain. In addition deep pain and visceral pain are poorly localized, 
nauseating and frequently associated with sweating and changes in blood 
pressure.  
 
 
 
Pain is classified as 
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Visceral Pain :  
In addition to being poorly localized, unpleasant and associated with 
nausea and autonomic symptoms visceral pain often radiates and is referred to 
other areas.  
 
The autonomic nervous system like the somatic has afferent component, 
central integrating stations, and effecter pathways. The receptor for pain and 
the other sensory modalities present in the viscera are similar to those in skin, 
but there are marked differences in their distribution.  
 
 There are no proprioceptors in the viscera, and few temperature and 
touch receptors and nociceptor are present although they are more sparsely 
distributed than in somatic structure. 
 
FUNCTIONAL ANATOMY 
The brachial plexuses supplies innervations to the upper limb which 
consists of a branching network of nerves derived from the anterior Rami of the 
lower four cervical and the first thoracic spinal nerves starting from their origin 
and descending distally, The component of the plexus named Roots, Trunks, 
Divisions, Cords,  and finally terminal branches. Five Roots of the cervical and 
the first thoracic spinal nerves (antertior rami) give rise to three trunks 
(superior, Middle and inferior) that emerge between medial and antertior 
scalene muscles to lie on the floor of the postertior triangle of the neck. The 
roots of the plexus lie deep to the prevertebral facia, Where  as the trunk is 
covered by its lateral extensions, The divisions combine to produce three cords, 
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Which are named lateral, Medial, and Posterior according to their relationship 
to the axillary artery from this point on, individual nerves are formed as these 
neuronal elements descend distally. 
 
 
 
 
 
 
 
 
 
Fig. 9. Anatomy of brachial plexuses in a dissected Arm    
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Table 1 : Distribution of the brachial Plexuses : 
Nerve (S) 
Spinal 
Segment(S) 
Distribution 
Nerve to Subclavius  C5, C6 Subclavius Muscle  
Dorsal Scapular N C5 Rhomboid Muscle and levator scapulae 
muscle 
Long thoracic nerve C5 through C7 Serratus anterior muscle  
Suprascapular nerve C5, C6 Subscapularis and teres major muscle 
Pectoralis nerve 
medical and lateral  
C5 through T1 Pectrolis Muscle  
Subscapular nerve  C5 – C6 Subscapularis and teres major muscle  
Thorocodorsal  C6 through C8 Lattisms dorsi muscle 
Axillary Nerve  C5 and C6 Deltoid and teres minor muscle, skin of 
shoulder  
Radial Nerve C5 through T1 Extensor muscle of arm and forearm 
(triceps branchi, extensor carpiradialis, 
extensor carpi ulnaris), supinator, 
anconeus and branchioradialis muscle 
digital extensors and abductor pollicis 
longus muscle, skin over the posterola 
loral surface of arm, forearm, and hand  
Musculocutaneous 
nerve 
C5 through C7 Flexor muscle of the arm 
(bicepsbrachii, brachialis, 
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coracobrachials) skin over the lateral 
surface of the forearm. 
Median Nerve  C6 through T1 Flexor Muscle of the forearm (Flexor 
Carpi radialis, Palmaris longous) 
Pronator Quadaratus, pronator teres 
muscle digital flexor (through the 
palmar Interosseus nerve skin over 
anterolateral surface of the hand.  
Ulnar nerve C8 and T1 Flexor carpi ulnars muscle, adductor 
policis muscle the hypothenar muscle 
and the small digital muscles, skin over 
the medial surface of the hand.  
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PHARMACOLOGY 19,37,38,39 
 
Local anesthetic are drugs that produce reversible conduction blockade 
of impulses along the central and peripheral nerve  pathways .Peripheral nerve 
block anesthesia is achieved by injection of local anesthetic solution into 
tissues surrounding individual peripheral nerves or nerve plexuses such as 
brachial plexuses. When local anesthetic solution is injected into the 
concentration gradient (Winnio at 91, 1977 b) consequently, Nerve fibers along 
mantle of the mixed nerve are anesthetized first. These mantle fibers are 
usually distributed to more proximal anatomic structures in contrast to distal 
structures innerved by the nerve fibers near the core of the nerve. This explains 
the initial development of anesthesia proximally, with subsequent distal spread 
as local anaesthetic solution diffuses to reach the more central core fibers 
conversely recovery of sensation occurs in reverse directions. So that sensation 
returns initially to the proximal and last to the distal parts of the limb. 
 
Skeletal muscle paralysis may precede the onset of sensory anaesthesia, 
If motor nerve fibers are distributed peripheral to the sensory fibers in the 
mixed peripheral nerves indeed, The sequence of onset and recovery from the 
blockade of sympathetic, sensory and motor nerve fibers in a mixed peripheral 
nerve depends as much nerves as on their sensitivity to local anaesthetics. This 
differs from results of invitro studies on single nerve fibers. In which diffusions 
does not play a role. In an invitro model, Nerve fiber size is most important, 
with the onset of conduction blockade being inversely proportional to fiber 
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size. For example the smallest sensory and autonomic nervous system fibers 
are anesthetized first, followed by larger motor and proprioceptive axons. The 
rapidity of onset of sensory anesthesia after injection of a local anesthetic 
solution into tissue around a peripheral nerve depends on pka of the drug, The 
pka determines the amount of local anesthetics that exists in the active non 
ionized form at the pH of the tissues, For example The onset of action of 
lidocaine occurs approximately 15 minutes, reflecting the greater fraction of 
lidocaine that exist in the lipid soluble non ionized form The onset and duration  
of sensory anesthesia for brachial plexus block produced by 0.5% bupivaicaine, 
Levobupivacaine or ropivacaine is similar. 
 
Duration of peripheral nerve blockade depends on the dose of local 
anesthetic, its lipid solubility, its degree of protein binding and concomitant use 
of vasoconstrictor such as epinephrine. The duration of action is prolonged 
more safely by epinephrine than by increasing the dose of local anesthetic, 
which also increase the likelihood of systemic toxicity. Bupivacaine combined 
with epinephrine may produce peripheral nerve block anesthetic lasting upto 14 
Hours. Conversely not all reports documented a prolongation of the duration of 
action when epinephrine is added to bupivacaine or ropivacaine. 
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STRUCTURE RELATED ACTIVITY OF LOCAL ANESTHETICS. 
Local anesthetic consists of a lipophillic and a hydrophillic portion 
separated by connecting a hydrocarbon chain. 
 
 
 
 
 
Hydrophillic is usually a tertiary amine such as diethylamine where as 
lipophillic portion is usually an unsaturated aromatic ring, Such as para amino 
benzoic acid. The lipophillic portion is essential for anesthetic activity and 
therapeutically useful local anesthetic require a delicate balance between lipid 
solubility and water solubility in almost all instances, an ester (-co-) or an 
amide (-NHC-) bond links the hydrocarbon chain to the aromatic rings. The 
nature of this bond is the basis for classifying drugs that produced conduction 
blockade of nerve impulses as an ester local anaesthetic or amide local 
anaesthetics. The important differences between ester and amide local 
anaesthetic relate to the site of metabolism and the potential to produce allergic 
reactions. 
 
Modification of Chemical Structures 
Modifying the chemical structure of a local anaesthetic alters its 
pharmacological effects. For example, lengthening the connecting hydrocarbon 
chain or increasing the number of carbon atoms on the tertiary amine or 
C 
 
O 
H2N 
 
 
Lipophillic 
O CH2 CH2 
C2 H5 
C2 H5 
N 
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aromatic ring often results in local anesthetic with different lipid solubility, 
potency, rate of metabolism and duration of action. Indeed, substituting a butyl 
group for amide group results in tetracaine compound with procaine, 
Tetracaine is more lipid soluble, is ten times more potent, and has a longer 
duration of action corresponding to a four to five fold decrease in the rate of 
metabolism. 
 
Structure of Lidocaine 
 
 
 
 
 
 
 
CLASSFICATION OF LOCAL ANAESTHETICS 
Esters Amides 
Procaine Lidocaine 
Chlaroprocaine Etidocaine 
Tetracaine Prilocaine 
 Mepivaicaine 
 Bupivacaine 
 Levobuvacaine 
 
CH3 
Lidocaine 
NH  C CH2 N 
C2 H5 
C2 H5 
O CH3 
Lidocaine 
NH C 
O N 
CH3 
CH2–CH2–CH2–CH3  
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MECHANISM OF ACTION 
 
Local anesthetic prevents transmission of nerve impulse (Conduction 
Blockade) passage of sodium ions through ion-selective sodium channels in 
nerve membranes. The sodium channel itself is a specific receptor for local 
anesthetic molecules. Occlusion of open sodium channels by local anesthetic 
molecules contributes little to over all inhibition of sodium permeability. 
Failure of sodium ion channel permeability to increase, slows, the rate of 
depolarization such that threshold potential is not reached and thus an action 
potential is not propagated. Local anaesthetic do not alter the resting 
transmembrane potential or threshold potential 
 
SODIUM CHANNELS 
 
 
 
 
 
   
 
 
Fig. 10. Sodium Channels 
 
The sodium channel consists of large sodium-conducting pore (Alpha 
Subunit) and varying number of adjacent beta subunits. The large polypeptide 
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that forms the alpha subunit is further divided into four subunits DI-IVH is the 
alpha subunit is further allows ion conduction and binds to local anesthetics 
binding to the sodium channel are stero specific and depends on the 
conformational state of sodium channel. Sodium channels exist in activated 
open, inactivated-closed and resting closed states during various phases of the 
action potential. In the resting nerve membrane, sodium channels are 
distributed in equilibrium between resting closed and inactivated closed states. 
By selectively binding to sodium channels in inactivated-closed states local 
anesthetic molecules stabilizes. These channels in this configuration and 
prevent their change to the rested-closed and activated open states in response 
to nerve impulses. Sodium channels in the inactivated-closed state are not 
permeable to sodium and thus conduction of nerve impulses in not propagated. 
It is speculated that local anesthetics binds to specific sites located on the inner 
portion of sodium channels as well as obstructing sodium channels near their 
external open in as to maintain these channels in inactivated closed states. This 
binding appears to be weak and to reflect a relatively poor fit of the local 
anesthetic molecule with receptor. This is consistent with broad variety of 
chemical structures that exhibit local anaesthetic activity on sodium channels. 
 
FREQUENCY – DEPENDENT BLOCKADE 
Sodium ion channel tend to recover from local anesthetic induced 
conduction blockade between action potentials and to develop additional 
conduction Blockade. Each time sodium channels open during an action 
potential (Frequency-Dependent Blockade). Therefore, Local anaesthetics 
29 
 
molecules can gain access to receptors only when sodium channels are in 
activated open state. For this reason, Selective conduction blockade of nerve 
fibers by local anaesthetics may be related to the nerves characteristic 
frequency of activity as well as to its anatomic properties. Indeed, a resting 
nerve is less sensitive to local anaesthetic - induced   conduction blockade than 
is a nerve that has been repetitively stimulated. Etidocaine characteristically 
blocks motor nerve before sensory nerve because of frequency dependent 
blockade. 
 
MINIMUM CONCENTRATION 
The minimum concentration of local anesthetic necessary to produce 
conduction blockade of nerve impulses is termed the cm. The cm is analogous 
to the minimum alveolar concentration for inhaled anaesthetics. Nerve fibers 
diameter influences cm with larger nerve fibers requiring higher concentration 
blockade. An increased tissue pH or high frequency of nerve stimulation 
decreases cm. 
 
Each local anaesthetics has unique cm. reflecting differentials potencies 
of each drug The cm of the motor fibers is twice of sensory fibers thus sensory 
anesthesia may not always be accompanied by skeletal muscle paralysis. 
Despite an unchanged cm, less local anesthetics is needed for subarachnoid 
anaesthesia than for epidural anaesthesia, reflecting greater access of local 
anaesthetic to unprotected nerves in subarachnoid space.  
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Peripheral nerves are comprised of myelinated A and B fibers and 
unmyelinated C fibers. A minimal length of myelniated nerve fiber must be 
exposed to an adequate concentration of local anaesthetics for conductions 
blocked of nerve impulses to occur. For example, if only one node of Ranvier 
is blocked (site of change in sodium permeability) the nerve impulse can jump 
(skip) across this node and conduction blockade does not occurs. For 
conduction blockade to occur in a fiber it is necessary to expose atleast two and 
preferably three successive nodes of Ranvier to a adequate concentration of 
both types of pain conducting fibers (myelinated). A delta and non myelinated 
(fibers) are blocked by similar concentration of local anaesthetics, despite the 
differences of these fibers. Pregangilonic – B fibers are more readily blocked 
by local anaesthetics than any fibers, eventhough these fibers are myelinated.  
 
Pharmacokinetics 
 Local anaesthetics are weak bases that have pka valves somewhat above 
physiological pH. As a result <50% of local anaesthetics exists in lipid soluble 
non ionized form at physiological pH. Intrinsic vasodilator activity will also 
influence apparent potency and duration of action.   
 
Absorption and Distribution  
 Absorption of local anaesthetics from its site of injection in to the 
systemic circulation is influenced by the site of injection dosage, use of 
epinephrine and pharmacologic characteristics of drug. The ultimate plasma 
concentration of local anaesthetic is determined by the rate of tissue 
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distribution and the rate of clearance of drug. Lipid solubility of the local 
anaesthetic is important in this redistribution, as well as being primary 
determinant of intrinsic local anesthetic potency. After distribution to highly 
perfused tissues, the local anaesthetic is redistributed to less well perfused 
tissues, including skeletal muscles and fat. Consideration of cardiac output is 
important for describing the overall tissue distribution. In addition to tissue 
blood flow and lipid solubility of the local anaesthetics, patient related factors 
such as age, cardiovascular status, and hepatic function will also influence the 
absorption and resultant plasma concentration of local anaesthetics. Protein 
binding of local anaesthetics will influence their distribution and execution. In 
this regard protein binding parallels lipid solubility of the local anaesthetics and 
is inversely related to plasma concentration of the drug. Overall after systemic 
absorption amide local anaesthetics are more widely distributed in tissues than 
ester local anaesthetics.  
 
Lung extraction : 
 The lungs are capable of extracting local anaesthetics, such as lidocaine, 
bupivacaine and prilocaine from the circulation. After rapid entry of local 
anaesthetics into the venous circulation, this pulmonary extraction will limit the 
concentration of drug that reaches the systemic circulation for distribution to 
the coronary and cerebral circulation. For bubivacaine, this first pass 
pulmonary extraction is dose dependent, suggesting that the uptake process, 
became saturated rapidly. Propranolol impairs bupivacaine extraction by the 
lungs, perhaps reflecting a common receptor site for the two drugs. 
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Furthermore, propranolol decreases plasma clearance of lidocaine and 
bupivacaine, presumably reflecting propranolol induced decreases in hepatic 
blood flow or inhabitation of hepatic metabolism.  
 
Metabolism of amide local anaesthetics : 
 Amide local anaesthetics undergo varying rates of metabolism by 
microsomal enzhymes located primarily in the liver. Prilocaine undergoes the 
most rapid metabolism. Lidocaine and mepivacaine are intermediate and 
Etidocaine, Bupivacaine and ropivacaine undergo the slowest metabolism 
among the amide local anaesthetics. The initial step is conversion of the amide 
base to amino carboxylic acid and a cyclinic anilide derivative. Complete 
metabolism usually invokes additional steps such as hydroxylation of aniline 
moiety and idealkylation of amino carboxylic acid compared with that of ester 
local anaesthetics, the metabolism of amide local anaesthetics is more complex 
and slower. This slower metabolism means that sustained increases of plasma 
concentration of amide local anaesthetics and thus systemic toxicity are more, 
cumulative drug effects of amide local anaesthetics are more likely than with 
ester local anaesthetics.  
 
Lidocaine  
 The principal metabolic pathology of lidocaine is oxidative dealkylation 
in the liver to monoethylglycine xylidide followed by hydrolysis of this 
metabolic to xylidide. Monoethylglycine xylidide has approximately 80% of 
the activity of lidocaine for protecting against cardiac dysrhythmias in an 
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animal model. This metabolite has a prolonged elimination. Half time, 
accounting for its efficacy in controlling cardiac dysrhythmic after the infusion 
of lidocaine is discontinued. Xylidide has only approximately 10% of the 
cardiac antidysrrhythmic activity of lidocaine. In human, approximately 75% 
of xylidide is excreted in the urine as 4-hydroxy 1-6 dimethylanilide.  
 
 Hepatic disease or decrease in hepatic blood flow which may occur 
during anaesthesia can decease the rate of metabolism of lidocaine. For 
example, the elimination half time of lidocaine is increased more than fivefold 
in patients with liver dysfunction compared with normal patients. Decreased 
hepatic metabolism of lidocaine is anticipated when patients are anaestheized 
with volatile anaesthetics. Maternal clearance of lidocaine is prolonged in 
presence of pregnancy included hypertension and repeated administration of 
lidocaine can result in higher plasma concentrations than in Normotensive 
parturient. 
 
Bupivacaine  
 Possible pathway for metabolism of bupivacaine include aromatic 
hydroxylation, N-dealkylation, amide hydrolysis and amide hydrolysis and 
conjugation. Only the N-dealkylated metabolite – N desbutyl bupivacaine has 
been measured in blood or urine after epidural or spinal anaesthesia. The mean 
total urinary execretion of bupivacaine.  
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Structure of Bupivacaine 
 
 
 
 
 
 
 
 
 
 
 
Bupivacaine is an amide type of analgesia drugs. It is a hydrochloride salt of l 
butyl - N - (2, 6 dimethyl phenyl) Piperidine - 2 - Carboxamide.  
 It was synthesized in Sweden by Exenstam and his colleagues in 1957. 
 First used clinically by L.J.Telivuo in 1963. 
 Pka is 8.2 
 Molecular wt-288 
 Protein binding-95% 
 Lipid solubility-28% 
 Elimination half life -210mts. 
 Toxic plasma concentration-1.5uglml 
 Approximate duration of action-175 mts 
 It decreases central venous pressure. 
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 It causes increases in lower limb blood flow. 
 It causes a reduction in incidence of deep vein thrombosis. 
 
Respiratory System 
It relaxes bronchial smooth muscle. It causes aphnea due to phrenic and 
inter costal nerve paralysis on depression of medullary centers. 
 
Gastro Intestinal Tracts 
There is an increase in gastro intestinal motility and emptying of the 
gastric contents are better. 
 
 
Toxicity 
Toxicity is replaced to plasma level of unbound drug and more likely 
due to an inadvertent intravenous injection. Systemic toxicity reactions 
primarily involve central nervous system and cardiovascular system. The drug 
is very stable to acids, alkalis, and repeated autoclaving bupivacaine is 0.5% is 
the preferred strength.  Higher concentration result in greater variability of 
spread. 
 
Bupivacaine 4 times as potent as lignocaine, hence 0.5% solution is 
approximately equivalent- to 2% lignocaine. It is more cardiotoxicthan 
lignocaine which is aggravated by hypoxia, Hypercapnia and pregnancy it 
causes more sensory than block. It is not recommended for Intravenous 
regional analgesia. 
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Duration of effect is between 5 and 16 hours and is one of the longest 
acting local analgesics, which is related to binding of it the nerve tissues. 
 
The mechanism by which local anesthetics block sodium channel 
conductance is as follows. 
 
Local anesthetics in the cationic form act on the receptors within the 
sodium channels on the cell membrane and block it. The local anesthetic can 
reach the sodium channel either via lipophilic pathways directly across the lipid 
membrane or through the agronomic plasmic. 
 
Pharmacodynamics 
It decreases the cardiac output by decreasing the tone of sympathetic 
system by slowing the heart rate or by reducing the venous return. It produces a 
fall in arterial blood pressure but it is relatively slow and sodium very profound 
is metabolized in the liver. 
Uses :  
− Spinal anesthesia. 
− Epidural anesthesia. 
− Caudal anaesthesia. 
− Continuous epidural anesthesia. 
− Peripheral nerve blocks. 
− Infiltration anesthesia. 
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Site of action Onset (Minutes) Duration (Minutes) 
Intrathecal 5 90 – 120 
Epidural 15 – 20 165 – 225 
Brachial Plexus 10 – 20 600 
 
Alphal acid glycoprotein is the most important plasma protein binding 
site of bupivacaine. The concentration of bupivacaine is increased in many 
situations such as post operative trauma. 
Excretion 
It is through kidney 4-10% of the drug is excreted unchanged. 
 
Mode of action. 
a) Site of action. 
(i) The spinal nerve rootlet fine nerve filaments having large surface area 
are exposed to local anesthetics. 
(ii) Posterior and lateral aspects of spinal card. 
(iii) Sodium channel blockade; 
 
They impede sodium ion access to the axon interior by occluding the 
transmembrane sodium channels thus delaying the process of depolarization 
and axons remain polarized. It is a non-depolarization. 
 
Pharmacokinetics 
It gets absorbed through nerve rootlets and it is rapidly absorbed from 
the site of injection, but the rate of absorption depends on the vasuclarity and 
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the presence of vasoconstrictors. Because of high lipid solubility it easily 
penetrates nerves and vascular tissues. 80-95% of absorbed bupivacaine binds 
to plasma proteins. 
 
Distribution 
 Rapid distribution phase I (α) 
 Slow disappearance phase II (β) 
 
Biotransformation 
Possible pathways of metabolism of bupivacaine include aromatic 
hydroxylation and conjugation. Only the N-dealkylated metabolite N-desbutyl 
bupivacaine has been measured in the blood or urine after epidural or spinal 
anaesthesia. The blood level required to produce central nerves system toxicity 
is less than that required to produce circulatory collapse. 
 
Central nervous system toxicity early symptoms are circumoral numbness 
tongue paraesthesia, and dizziness. Sensory complaints included tinnitus and 
blurred vision.   
 
Excitatory signs (restlessness, agitation, nervousness, paranoia) often 
precede, central nervous system depression (slurred speech, drowsiness, 
unconsciousness). Muscle twitching heralds the onset of tonic clonic seizures. 
Respiratory arrest often follows. The excitatory reactions are the result of 
selective blockade of inhibitory pathways. The rate of depolarization in fast 
conducting tissues purkinje fibers and ventricular muscle is decreased.  
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Extremely high concentration of the drug causes sinus bradycardia, 
hypotension, AV block, idioventricular rhythm and life threatening arrhythmias 
such as ventricular tachycardia, ventricular fibrillations, and cardiac arrest. 
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TREATMENT OF BUPIVACAINE TOXICITY 
 
CNS Toxicity 
Convulsions treated by adequate ventilation with oxygenation and 
controlled by anti convulsions Diazepam (10-20mg 1.V) repeated if 
necessaries) or alternatively, thiopental (150-250mg) Intravenously Treatment 
includes mechanical ventilation and circulatory support and use vasopressor 
may be indicated. 
 
CVS Toxicity. 
If ventricular tachycardia, ventricular fibrillation and cardiac arrest 
occurred then Bretylium is drug of choice. Phenytoin and amidarone are also 
used. Usage of 20% lipid emulsion will reduced the toxicity of bupivacaine by 
binding to it. 
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REVIEW OF LITERATURE 
 
• "II feld BM, Enneking FK et al., 8 Anestn. Analog 2005, 100 : 1822 – 33 
Perineural analgesia which can be used as a ambulatory basis, provided 
statistically superior analgesia at rest and with activity for 48 – 72 hrs with 
reduction in risk of nausea and vomiting, but increased risk of motor block, 
Clinically superior analgesia was apparent at rest for the first 24 hrs and 
with activity for 48 hours".  
 
• "Aguirre et al., 9 (2012) stated that the most common use of C-PNB is in the 
peri and post operative period but different indications have been described 
like treatment of chronic pain such as cancer induced pain, complex 
regional pain syndrome or phantom limb, The documented benefit strongly 
depends on the analgesia quality and includes decreasing baseline / 
dynamic, reading analgesic requirement decrease of post operative joint 
inflammation and inflammatory markers".  
 
• "Tamosuina R’, Gudas R, Karbonskiene A, Marchetiene10 I studied efficacy 
of continuous interscalene brachial plexus block with bupivacaine 0.17% 
for post operative analgesia after shoulder surgery and concluded that 
bupivacaine showed less pain at rest and in motion than the placebo group 
except 4 h and 6 h after brachial plexus block, requirement of supplemental 
analgesia was also lower., Side effects, circulatory and respiratory 
parameters were comparable in both groups. Satisfaction scores were higher 
in bupivacaine group".  
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• "Rawal et al.,11 1994 described outpatient perineural infusion using a 
percutaneous catheter and a small light weight, He described ambulatory 
perineural infusions in various anatomic locations including paravertebral, 
interscalene, intersternocleidomastoid, infraclauicular, axillary, psoas 
compartment".  
 
• "Klein et al12 provided the first prospective evidence quantifying infusion 
benefits in 2000, This randomized double – masked placebo – controlled 
investigation involving subjects undergoing open rotator cuff repair who 
received an interscalene block and perineural catheter preoperatively and 
they were randomized to receive either perineural Bupivacaine 0.25% or 
normal saline postoperatively 10m/hr, Patient receiving perineural placebo 
averaged 3 on a visual analog pain scale of 0 to 10, compared with 1 for 
subjects receiving 0.25% Bupivacaine".  
 
• "J.E. Chelly, D. Chisti and A. Fanneii13 conducted a study in (University of 
Pittsburgh Medical Centre) says that continuous nerve blocks have proved 
safe and effective in reducing opiod consumption and related side effects, 
accelerating recovery and in many patients reducing the length of stay in 
Hospital. Continuous nerve blocks provides a safer alternatives to epidural 
analgesia in patients receiving thromboprophylaxsis especially with low 
molecular weight heparin, and concluded that continuous nerve blocks 
represents an important therapeutic tool in managing perioperative pain and 
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trauma pain, They have been proved safe and effective, especially when 
combined with multimodal approach to pain management.  
 
• Ingo Bergmann,  Maximillian Heetfeld, Thomas A Crozier, 14 did a study 
which was published in central European Journal of Medicine to know 
whether peripheral nerve block gives greater hemodynamic stability than 
general anesthesia in ASA III patients undergoing knee orrthroscopy, 
outpatient with preexisting. Cardiovascular and pulmonary disorders and 
they concluded that peripheral nerve block provides a more stable 
hemodynamic course than general anesthesia in ASA III patients.  
 
• Brain et al., in University of California, Sanniego15 did a research study to 
determine if the effects of continuous peripheral nerve blocks are influences 
by the distance of insertion past the needle tip of the perineural catheters 
concluded that the hip of the needle past 3 - 5cms had better pain score than 
0 – 1 cms".  
 
• "Charles Pham-Dang16 published an article in Regional Anesthesia and pain 
medicine, they evaluated the efficacy of stimulating catheters that were 
used for continuous peripheral nerve blocks as a means of immediate 
verification and confirmation of correct catheter position. The intensity of 
current used to elicit motor responses typically was higher with the catheter 
than with the introducer needle and thus concluded that the ability to electro 
stimulate nerves using an insitu catheter increases success in catheter 
placements for continuous peripheral nerve blocks".  
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AIM OF THE STUDY 
Aim  
 “To compare the efficacy of continuous peripheral nerve blocks over 
single shot peripheral nerve blocks (S-PNB), in upper limb orthopedic 
surgeries.”  
 
Primary Objective  
 This randomized comparative study is to determine whether the post 
operative pain relief incidence of Break through pain and requirement of rescue 
analgesia is reduced as published in literatures.  
 
Secondary Objectives :  
1. Effectiveness of pain relief at mobilization.  
2. Supplemental analgesia, if used  
3. Time to mobilization  
4. Patients’s satisfaction  
5. Length of stay in Hospital  
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MATERIALS AND METHODS 
 
Study design 
This was a single centre, prospective, randomized, non blinded 
comparative study conducted in the department of Anesthesiology. Tirunelveli 
Medical College, Tirunelveli from June 2015 to August 2015. 
  
After obtaining our College Ethical Committee approve 60 adult 
patients of both sexes, within the age group of 10 to 60 years. Belonging to 
ASA 1&2 undergoing orthopedic surgeries upper limbs were selected. They 
were randomized using computer generated random numbers and allocated into 
two groups, Groups SS and CS. 
 
Group SS: Received single shot peripheral nerve blocks. 
Group CS: Received continuous peripheral nerve blocks. 
 
Study population 
Inclusion criteria 
1. Age 10 to 60 years  
2. ASA 1 and 2 
3. Elective cases posted for upper limb orthopedic surgeries 
4. BMI < 30 kg/m2 
 
Exclusion Criteria 
1. Infection near the site of Insertion. 
2. Coagulation disorders. 
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3. Known allergy to local anesthesia. 
4. Prior surgeries at the site of nerve block. 
5. Pregnancy & lactation. 
6. Known hepatic or Renal Insufficiencies. 
7. Pre-existing neurological deficit of operated upper limb. 
8. Any abnormal shoulder anatomy. 
9. Patients refusal. 
10. Patients request for General anaesthesia. 
 
Sample Size is 60 patients, 30 patients in group SS and 30 patients in Group 
CS. 
 
Pre operative Evaluation 
In patients  
Age 
Sex 
Body weight in kgs 
Height in cms 
Body mass index kg / m2 
Baseline parameters were recorded. 
 
History regarding 
- Previous anaesthesia, surgery. 
- Any significant medical illness. 
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- Medications. 
- Allergies were recorded 
 
Following laboratory investigations done.  
 Haemoglobin % 
 Blood Sugar & Urea 
 Serum creatinine  
 Urine analysis  
 Chest X-ray and ECG 
 Bleeding time and clotting time 
 Screening for HIV, HBsAg. 
 
Study Method  
 After getting approval from the institutional ethical committee informed 
written consent were obtained from the patients. The patients were randomly 
allocated into groups 2 according to computer generated random numbers.  
 
Preliminaries  
1) For the procedure  
 A portable tray covered with sterile towels containing Syringes of 10 ml, 
2 ml. 
 Hypodermic needle of 1 cm length 22 G. 
 Povidone iodine and spirit. 
 Sponge holding forceps. 
 Towel clips  
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 Sterile Gauze  
 
2) For emergency resuscitation  
 The anesthesia machine which is working  
 Emergency O2 supply  
 Pipeline O2 supply  
 Working laryngoscopes  
 Appropriate size ET – 6.5, 7, 7.5, 8 
 Working suction apparatus 
 intravenous fluids  
 Drugs Thiopentone, diazepam, succinyl choline, Hydrocortisone, 
Atropine, Adrenaline, Aminophylline, mephenteramine, calcium 
gluconate and sodium bicarbonate. 
 
3) Monitors : 
 Pulse Oximeter  
 Non invasive blood pressure monitored by sphygmomanometer.  
 Sphygmomanometer 
 
Premedication given with injection atropine at a dose of 20 µg / kg intra 
muscularly 3/4th hour before surgery 1.v cannula with 18 G Needle secured in 
contralateral arm. Ringer lactate is started. Standard monitors according to 
ASA guidelines were used. Heart rate, mean arterial pressure and SPO2 were 
recorded before surgery and at regular intervals after the surgery.  
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Procedure for single shot peripheral nerve block 20,21,22 
A) Supraclavicular  
1) Patient lies supine, arms by the side and head turned to slightly opposite 
side.  
a. Identify the interscalene groove and mark the midpoint of clavicle. With 
strict aspectic precautions the groove between scalene medius and 
scalene anterior known as interscalene groove is identified. First, finger 
is insinuated behind posterior border of sternocleido mastoid muscle, 
which is marked as first groove, finger rolled out little lateral and then 
palpated second groove which is interscalene groove. A midpoint of 
clavicle is made a point of around 2 cms above that point sub clavian 
artery is palpated. A skin wheal is raised just cephalo posterior to the 
artery then a 22 G 5 cm needle mounted on a 20 ml syringe was passed 
through the same point parallel to the head and neck, caudally and 
medially and posteriorly, until the paraesthesia could be elicited, After 
confirmation with negative aspiration of the blood 40 ml of mixture 
containing 20 ml of 0.5% Bupivacaine and 20 ml of 2% lidocaine given 
making sure that the amount of drug does not exceed the toxic dose 
calculated for that patient. Patient’s HR, MAP, SPO2 monitored during 
and after surgery.   
1. VAS Score Calculated for 1h, 2h, 6h, 12h, 24h, 48h postoperatively. 
2. Break through pain complained during 48 hours postoperative period is 
recorded. 
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3. Rescue Analgesia given during this period is recorded.  
4. Opiod related side effect, if occurs recorded. 
 
b. Interscalene Block23,24,25,26 : Palpation of the interscalene groove is 
done with patient lying supine and head rotated to approximately 20 to 
250 to contralateral side. The external jugular vein often crosses the 
interscalene groove at the level of cricoid cartilage, Needle is inserted 
medially and at caudal angle, advanced to elicit paraesthesia after 
negative aspiration of blood 20 ml of 0.5% Bupivacaine and 20 ml of 
2% lidocaine with adrenaline (2,00,000 dilution) making sure that the 
dose does not exceed the toxic dose calculated for that patients. 
 
c. Axillary Block27,28,29 : Patient is positioned supine with arm abducted to 
900 and head turned to contralateral side. The axillary artery pulse is 
palpated and location is marked. Two needle passed and a 20 ml of 40 
ml of mixture containing (20 ml of 0.5% Bupivacaine + 20 ml of 2% 
lidocaine given), making sure that the dose does not exceed the toxic 
dose calculated for that patients.  
 
VAS score, break through pain, and rescue analgesia assessment done as for 
supraclavicular written above. 
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Visual analogue scale (pain scale) usually respondents are asked to report 
current pain intensity in the last 48 hours.  
 
The pain visual analogue scale is self completed by the respondents. The 
respondent is asked to place a line perpendicular to the VAS line at that point 
that represents their pain intensity. After the patient has marked, using a ruler, 
the score is determined by measuring the distance on the 10 cm line between 
the “No Pain” to severe pain.  
 
 The score can be 0 – 10. A higher score indicates greater pain intensity. 
Based on the distribution of the pain, VAS score in the post surgical patients, 
the following cut points on the pain VAS have been recommended.  
 No pain (0 – 1) 
 Mild pain (2 – 4) 
 Moderate pain (5 – 7) 
 Severe pain (8 – 10) 
 
 
 
 
52 
 
Significance of visual analog scale : 
 Pain visual analogue scale is very easy to be used by respondent and 
assessor both. Woodford and Museky first reported use of VAS pain score. The 
reliability of the test has shown to be good and is higher among literate.  
 
Definition of Break through pain : 
Break through pain :  
 Discomfort, usually acute severe which is experienced by patients 
between the normal doses of medications that generally controls or palliates 
such pain.  
 
Definition of Rescue analgesia : 
 Rescue analgesia agents are medications prescribed in addition to 
regularly scheduled analgesic medications, which are intended to be taken 
during episodes of pain not controlled a patients scheduled analgesic regimen.  
  
Procedure of Continuous Perineural Block30,31,32,33,34,35   
Drugs and other equipments for the block procedure must be readily 
available in the room and prepared at bedside. Adverse effects and 
complication of peripheral nerve are reliably rare. However they do occur, 
immediate and acute invention is necessary to prevent serious complications. 
All drugs were neatly organized and made immediately accessible to us. 
Emergency drugs like atropine, adrenaline and propofol were made available to 
me throughout the procedure. For each patient, an i.v access with 18G needle is 
secured, supplemental oxygen was given, ECG monitoring was instituted, 
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when low intensity current nerve stimulation and slow nerve advancement was 
used. Interscalaene brachial plexus block was done with minimal patient 
discomfort. 1-3 mg of midzolam were given to most patients and make them 
co-operative during nerve localization following needle advancement as 
described below 30 ml of 0.25% of bupivacaine is injected, and a contiplex d 
catheter was used. With needle over technique and tip of the catheter passed 
beyond 3cms the needle tip and then. Tunnelling 42,43,44 was made to prevent 
slippage of catheter. At the site of exist of the catheter. Tuoh’s needle is 
inserted and stillet removed, catheter passed retrogradely and then removed at 
the point of exists and catheter fixed at the neck. Total duration of the 
technique is also recorded catheter is connected to a portable infusion pump in 
the PACU with Infusion regimen of 0.125% bupivacaine 5ml/hr with lock out 
period of 60 minutes40,41 and the following is observed.VAS score at 1hr, 2hr, 
6hr, 12hr, 24hr, 24hr post operatively. With VAS scare ranging from 0 to 10. 
No pain and 10 unbearable distresses. After 48 hours, removal of the catheter 
done and patient shifted to orthopedic post operative ward. 
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TECHNIQUE OF INTERSCALENE NERVE BLOCK 
 
In our study, Meire anterior approach is followed where the needle is 
inserted at the level of the superior thyroid notch along the posterior edge of the 
steno cleidomastoid muscle. The puncture was directed caudally slightly to the 
lateral side and aimed at the direction of Ipsilateral nipple. This technique has 
lower risk of inadvertent vessel puncture. Since this technique has lower risk of 
inadvertent artery puncture. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11 Anatomical Handmark of Interscalene Block 
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Fig. 12 Puncture site of interscalene block 
 
“The patient lyed supine, the arm to blocked is positioned comfortably 
on the abdomen and head turned away to contralateral side. Patient is asked 
slightly to elevate the head in order to make steno cleido mastoid muscle 
prominent. Care should be taken for the external jugular vein, which commonly 
exists in this area. After preparing the skin an antiseptic solution, and draping 
our field. A skin wheal is created at the site of puncture of 2% lidocaine with 
2,00,000 dilution adrenaline. A stimuplex D55mm 15 level, 22G conducting 
needle is used and connected to stimulator with current strength of 1mA. Pulse 
duration of 0.1 ms pulse frequency of 2Hz mounted to a 10 ml syringe with 
0.25% Bupivacaine + 2% lidocaine mixture. 
 
The direction of insertion is caudal, however, with discreet dorsal 
orientation relative to the body axis contraction in the region of biceps brachii. 
While montoring the stimulatory response, we reduced the stimulation current 
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of 0.2-0.3 MA is reached. If the stimulatory response is still trigerred, the 
needle must be retracted slightly. If visible muscle contractions occur and 
negative aspiration test done the local anesthetic injected slowly.  
 
TECHNIQUE OF SUPRACLAVICULAR BLOCK 
The technique is similar to interscalene block except the anatomical 
landmark and the puncture site. 
 
Anatomical Land Mark  
1. Clavicle 
2. Postertior Border of clavicle 
3. Inter scalene groove is marked as described in single shot technique.  
Palpation of the subclavian artery is done. 
 
Puncture site is 1 cm superior to the junction of medial 2/3rd and lateral 
1/3 of clavide, just behind subclavian artery. The stimulating needle is directed 
posterior, caudal and lateral to subclavian artery, 1 cm above the point marked 
in the clavicle as shown in the figure in single shot catheters. Tunnelling is 
done as described in interscalene technique. 
 
The catheter fixation and other measure are as above. 
Technique of axillary block. 
Anatomical land mark. 
a) palpate the axillary 
b) a Needle above the artery in Axilla high above. 
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c) Needle is passed high above the axilla at the axillary course, directing 
the needle posterior. 
 
VAS Score, Break through analgesia, and rescue analgesia is recorded 
as done for interscalene block. Protocol followed for supraclavicular and 
axillary block is same as interscalene block as described above.  
 
 
 Fig. 13. Comptipelex D Catheter  
 
 
Fig. 14. Nerve stimulator 
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RESULTS & ANALYSIS 
 
Statistical Analysis : 
Data analysis was done with the help of computer by using SPSS 
software and Sigma Stat 3.5 version (2012). Using this software percentage, 
mean, standard deviation and ‘p’ value were calculated through one way 
ANOVA, and Chi square test  and  P value of < 0.05 was taken as significant. 
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TABLE 2. AGE DISTRIBUTION  
 
Age in years Group SS Group CS 
 < 20 2 3 
 21 - 40   10 11 
 41 - 60  16 13 
 >  60 2 3 
Total 30 30 
Mean 43.6 43.2 
SD 14.5 15.5 
p value 0.918  Not significant 
 
Chart 1. AGE DISTRIBUTION  
 
 
 
The mean age in group SG is 43.6 and in group CS is 43.2, and p valve 
is >0.005 so not significant so comparable.  
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TABLE 3 : GENDER COMPARISON 
Gender Group SS Group CS 
Male 21 24 
Female 9 6 
Total 30 30 
p value 0.888  Not significant 
 
CHART 2 : GENDER COMPARISON 
 
 
The no of males in group SS and CS are 21and 24 respectively and 
female in both groups are 9 and 6 respectively and p valve is >0.005 not 
significant, so both groups are comparable.  
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TABLE 4 : COMPARISON OF WEIGHT 
Weight Group SS Group CS 
Mean 64.97 62.56 
SD 14.13 13.27 
p value 0.511  Not significant 
 
CHART 3 : COMPARISON OF WEIGHT  
 
The Mean weight in group SS is 64.9 kg and in CS group is 61.56, and p valve 
>0.005 not significant, so both groups are comparable.   
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TABLE 5 : COMPARISON OF HEIGHT 
Height Group SS Group CS 
Mean 164.93 162.74 
SD 5.63 5.53 
p value 0.144  Not significant 
 
CHART 4 : COMPARISON OF HEIGHT 
 
 
The mean height in SS group is 164.93 and in CS group is 162.74 and p value 
>0.005, so statistically not significant, so both groups are comparable. 
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TABLE 6 : COMPARISON OF MEAN BMI 
BMI Group SS Group CS 
 < 25   13 20 
 > 25   17 10 
Mean 23.72 23.1 
SD 4.31 3.99 
p value 0.581  Not significant 
 
CHART 5 : COMPARISON OF MEAN BMI 
 
 
The mean BMI in SS group is 23.7 and CS group is 23.1 and p value 
>0.005, so statistically not significant, so both groups are comparable and also 
satisfy the inclusion criteria. 
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TABLE 7 : COMPARISON OF PULSE RATE 
  
PULSE RATE SD 
p value 
Group SS Group CS Gr SS Gr CS 
PR 83.7 84.4 9.69 1.93 0.79 
 
 
CHART 6 : COMPARISON OF PULSE RATE 
 
 
The mean pulse rate between the groups is 83 and 84, and p <0.005, not 
significant, so both groups are comparable. 
.  
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TABLE 9 : COMPARISON OF SPO2 
 
  SPO2 SD p value 
    Group SS Group CS Gr SS Gr CS 
SPO2 99 99.5 0.83 0.78 0.019 
 
CHART 8 : COMPARISON OF SPO2 
 
 
The mean SPO2 in group SS is 99 and group CS is 99.5 p value is 0.019 
is taken as significant but this profile is not much significant, because SPO2 is 
99 and 99.5 SPO2 is measured as whole number and SPO2 within 95-100 is 
normal, so both groups are comparable though statistically significance is 
shown.  
98.7
98.8
98.9
99
99.1
99.2
99.3
99.4
99.5
Group SS Group CS
SPO2
99
99.5
Comparison Of SPO2
SPO2 Group SS SPO2 Group CS
66 
 
TABLE 10 : COMPARISON OF DURATION OF TECHNIQUE 
 
 
DURATION OF 
TECHNIQUE  IN SEC 
SD 
p value 
Duration of 
Techni 
Group SS Group CS Gr SS Gr CS 
Duration of 
Techni 
501.8 1109.9 89.5 173.7 < 0.001 
 
 
 
CHART 9 : COMPARISON OF DURATION OF TECHNIQUE 
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It is a well known fact that single shot takes 501 seconds in an average 
and continuous perineural catheter takes 1109 seconds, which is longer. This 
parameter is out of scope of our study, but separate studies have been done. 
The duration of technique is within the time taken as referred in various studies 
by us.  
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 TABLE 11 : COMPARISON OF VAS SCORE 
  VAS SCORE SD 
p value 
  Group SS Group CS Gr SS Gr CS 
 s 1 0.3 0.6 0.47 0.49 0.019 
2 0.93 0.67 0.37 0.48 0.019 
4 1.5 0.63 1.17 0.62 < 0.001   
12 5.2 1.07 1.24 0.74 < 0.001   
24 5.57 1.07 1.28 0.74 < 0.001   
S 48 6.27 0.97 1.08 0.41 < 0.001   
 
 
 
CHART 10 : COMPARISON OF VAS SCORE 
 
  
 
 
0.3
0.93
1.5
5.2
5.57
6.27
0.6 0.67 0.63
1.07 1.07 0.97
0
1
2
3
4
5
6
7
s 1 2 4 12 24 S 48
Comparison of VAS Score
VAS SCORE Group SS VAS SCORE Group CS
69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VAS Score is taken for 1st hour, 2nd hour, 6th hour, 12th hour, 24th hour, 
48th hour and found to be significant. The main aim of our study is to compare 
post operative pain relief, as VAS score shows statistically significance, it has 
thus elucidate the various literatures as reviewed as thus.  
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TABLE 12 : COMPARISON OF RESCUE ANALGESIA 
 
 
ANALGESIC SD p value 
 
Group SS Group CS Gr SS Gr CS   
Analgesic 4.53 0.53 1.25 0.73 < 0.001   
 
 
 
 
CHART 11 : COMPARISON OF RESCUE ANALGESIA 
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Break through pain and rescue analgesic score is found to be 4.53 in Group SS 
and 0.53 in Group CS and it is also significant.  
 
Thus statistical analysis proves that the postoperative pain relief, Break through 
pain and rescue analgesia score are less than 0.005 and they are statistically 
significant and thus this study has proved and elucidated as published in 
literatures reviewed by us.   
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DISCUSSION 
 
 “Single Shot peripheral nerve block had few problems like short 
duration of analgesia, frequent Break through pain, additional requirement of 
opioids, and high incidence of opioid related side effects but C-PNB has 
overcomed these problems. This study was carried out in 60 adult patients, to 
findout the efficacy of continuous perineural catheters.”  
 
 “J.E. Chelly, D. Chisti and A. Fenneii13 in their study, they concluded 
that continuous nerve blocks have proved safe and effective in reducing opioid 
consumption and related side effects, accelerating recovery reducing the length 
of stay in Hospital. This study also concluded that there is reduced 
postoperative analgesic requirement early recovery and reduced related opioid 
side effects.  
 
 “Klein et al 12 did a prospective study, and found that patient receiving 
continuous infusion of perineural 0.25% of Bupivacaine at 5 ml / hr averaged 1 
on a visual analogue pain.  This study is also proves that 0.25% Bupivacaine at 
5 ml/hr also averaged 1 on VAS Score.” 
  
 “IIfeld BM, Enneking FK et al19 did a study which showed that C-PNB 
provide superior analgesia at rest for first 24 hours and with activity for 48 
hours. This study concluded that C-PNB provided superior analgesia at rest for 
the first 18 hours and with activity for next 48 hours.”  
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 “Ingo Bergmaann et al15 did a study, where peripheral nerve block gives 
greater haemodynamic stability than general anaesthesia; this study also 
concluded that the haemodynamics parameters was stable during perioperative 
period.” 
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SUMMARY 
 
 In adult patient undergoing upper limb orthopedic surgery under various 
block techniques as described in materials and method found that the post 
operative pain relief is better in C-PNB, incidence of Break through pain, and 
requirement of rescue analgesia is related side effects.  
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CONCLUSION 
 
This study concluded that continuous peripheral nerve blocks provide 
better post operative pain relief, less incidence of break through pain reduction 
in requirement of rescue analgesia. The secondary objective of our study is also 
satisfied by better sleep quality, patient’s satisfaction, early post operative 
mobilization and early attendance to work.  
 
Thus this study has proved the benefits of continuous perineural 
catheters over single shot nerve blocks as published in review literatures.  
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PROFORMA 
 
TO ELUCIDATE THE BENEFIT OF CONTINUOUS PERINEURAL 
CATHETERS OVER SINGLE SHOT PERIPHERAL NERVE BLOCKS 
ACCORDING TO PUBLISHED LITERATURE 
 
Case No  :                                                                  I.P.no:-  
NAME  : 
ADDRESS    : 
AGE   :                
SEX    :                             
D.O.ADMISSION :  
HISTORY IN BRIEF :  
CLINICAL DIAGNOSIS/ INDICATION :  
 
EXAMINATION IN BRIEF :  
 Vitals  
∗ PULSE                  
∗ B.P-                       
∗ AIRWAY-ASSESSMENT  
 SYSTEMIC EXAMINATION  
 BASELINE HAEMODYNAMICS :  
∗ PR:                        
∗ BP:                                                 
∗ SPO2:  
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INVESTIGATIONS 
∗ COMPLETE BLOOD COUNT          
∗ RANDOM BLOOD SUGAR  
∗ BLOOD UREA SERUM CREATININE    
∗ BT CT                              
 
URINE EXAMINATION- ALBUMIN SUGAR MICROSCOPY  
CHEST X-RAY : 
 
ECG   : 
 
ASA GRADING :  
 
SURGICAL PROCEDURE :  
 
DURATION :  
 
PARAMETERS OBSERVED-  
VAS SCORE  
Break through Pain 
Rescue Analgesia  
Duration of Technique in Seconds  
 
Adverse Effects  
∗ Nausea +/-  
∗ Vomiting +/-  
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Intra operative monitoring 
 
Time After Block PR MAP SPO2 
5min    
10min    
20 min    
30 min    
45 min    
60 min    
EOS    
 
Post operative monitoring 
 
Time After Surgery PR MAP SPO2 
1H    
2H    
8H    
12H    
24H    
48H    
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Muha;r;rp xg;Gjy; gbtk; 
 
 ifapy; Vw;gLk; vYk;G KwpT mWit rpfpr;irf;fhf 
Njhs;gl;ilapy; cs;s euk;G $Lfspy; nrYj;jg;gLk; kaf;fkUe;J 
kw;Wk; njhlh; kaf;f kUe;J nfhLf;Fk; #oy; Vw;gLk; tpisTfs; 
gw;wpa Ma;T.  
 
ngah;    : 
taJ    : 
,dk;    : 
cs;Nehahsp vz; : 
mWit rpfpr;ir  : 
 
tpsf;fk; : 
 iffspy; Vw;gLk; vYk;G KwpTf;F nra;ag;gLk; mWit 
rpfpr;irf;fhf nrYj;jg;gLk; czh;tpof;fr; nra;Ak; Kiwapy; 
GgpNtnfa;d; vDk; kaf;f kUe;J> Njhs;gl;ilapy; cs;s euk;G 
$Lfspy; njhlh; Crp Foy; %yk; nrYj;jp mWit rpfpr;ir 
nra;tjdhy; Vw;gLk; gad;fs;> tpisTfs;> gf;f tpisTfs; gw;wp 
vdf;F ed;F Ghpfpd;w jkpo; nkhopapy; njspthf tpsf;fp $wg;gl;lJ. 
 
 vd;Dila milahsk; ve;j tifapYk; ,e;j Muha;r;rp %yk; 
ntspNa njhpahJ vd;gij mwpNtd;. ,e;j Muha;r;rpapy; ,Ue;J ve;j 
NeuKk; tpyfyhk; vd;gijAk; mjdhy; ghjpg;Gk; Vw;glhJ vd;gijAk; 
mwpNtd;.  
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 ehd; ahUila eph;ge;jKkpd;wp vd; nrhe;j tpUg;gj;jpd; Nghpy; 
RaepidTld; ,e;j Muha;r;rpapy; gq;F nfhs;s rk;kjpf;fpNwd;.  
 
 
,lk; :        ifnahg;gk; 
ehs; : 
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PR MAP SPO2 5m 10m 20 m 30 m 45 m 60 m EOS m
1 Sivasubramanian 45 M 45 160 17.6 I SS # R corawid with Gelnoia 83 97 99 408 88 84 76 69 87 88 88
2 Chockkalingam 65 M 60 169 21 II SS Segment # R humerus 84 95 99 400 85 80 76 72 69 70 72
3 Essakiammal 45 F 74 164 27.9 II SS # R humerus D/3 85 97 98 505 97 98 97 81 78 76 73
4 Sangeetha 29 F 78 172 26.4 II SS Supracondylor # L Humerus 98 88 99 600 87 85 79 77 75 75 78
5 Irudhayaraj 37 M 69 166 25 I SS # distal radius 65 94 100 603 99 100 91 87 84 93 95
6 Ramalakshmi 60 F 43 150 19.1 II SS # R Eeavicle 66 90 100 508 92 96 98 100 89 88 78
7 Kombiah 45 M 45 160 17.6 II SS # Surgical Neck of humerus 98 86 100 409 63 58 60 72 72 80 64
8 Saraswathy 55 F 75 164 27.9 II SS # L ULNT 102 87 99 635 84 96 96 98 99 76 78
9 Murugaraj 26 M 80 173 26.7 I SS AC Joints Disurption 78 97 99 438 92 99 98 84 80 82 82
10 Rangaswamy 55 M 75 164 27.9 II SS Old united # R. Clavicle 79 92 98 380 89 90 100 91 81 84 81
11 Muthu Hari 13 F 42 154 17.7 I SS Old A R Lateral enderclavicle 82 95 99 388 86 87 99 88 84 80 77
12 Bala Krishnan 44 M 80 172 27 II SS # ULNA B P 1/3 86 86 99 496 78 92 98 81 78 74 69
13 Ramaiah 27 M 80 173 26.7 II SS # BB A Forearm 103 84 100 630 84 86 100 82 80 74 72
14 Lakshmi 37 F 68 164 25.3 II SS Supracondylor # R Humerus 68 86 100 580 84 99 90 84 79 78 78
15 Velu 55 M 75 164 27.9 II SS 2 Part # numerus 74 88 100 583 86 89 100 82 80 74 78
16 Arunachalam 35 M 81 170 28 I SS Clavicle # M/3 L Side 73 84 98 610 82 89 98 82 86 78 79
17 Manohar 54 M 52 165 19.1 II SS # R scaphoid 86 89 98 435 86 88 90 93 96 87 82
Sl.No. Name of the Patient Age Sex Wt (Kgs) Ht         (cms) BMI ASA Group Diagnosis
Baseline
Duration of 
Technique in 
Seconds
Intra OP PR
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Sl.No.
5m 10m 20 m 30 m 45 m 60 m EOS m 5m 10m 20 m 30 m 45 m 60 m EOS m 1 H 2 H 4 H 8 H 12 H 24 H 48 H 1 H 2 H 4 H 8 H 12 H
93 86 84 77 79 79 80 97 98 98 99 99 99 99 68 78 80 77 88 77 77 92 88 84 76 78
96 88 73 64 63 63 80 100 98 100 98 100 100 100 74 79 88 84 85 88 85 88 96 78 78 80
98 101 97 90 90 84 82 99 97 98 96 95 100 100 81 84 85 99 91 99 99 84 98 101 97 98
98 99 98 90 84 82 71 98 97 98 98 99 99 99 75 77 81 78 75 75 78 99 99 98 100 100
89 89 101 87 76 69 70 96 96 95 99 98 97 99 78 83 75 73 85 85 85 65 94 96 98 100
93 92 103 91 72 81 80 99 99 97 98 99 100 100 80 78 92 86 86 87 88 90 88 94 94 88
97 96 98 98 97 98 99 100 100 100 100 100 100 100 69 78 81 86 91 86 86 86 88 88 86 88
73 91 84 88 76 78 78 98 99 100 100 98 99 100 79 76 96 88 81 88 88 87 88 86 80 90
71 93 103 91 72 81 81 97 99 99 99 87 99 72 77 78 79 72 78 78 92 85 80 72 79
74 87 82 84 86 76 72 97 98 99 99 98 98 78 79 82 86 78 78 78 95 87 72 65 64
97 88 84 76 74 85 82 99 99 98 97 99 99 79 79 82 82 86 89 80 99 102 98 91 91
97 96 97 87 82 77 79 98 99 99 99 100 100 69 68 69 72 74 77 80 98 99 100 100 100
91 84 88 84 76 76 76 97 98 99 99 100 100 74 76 78 79 80 86 88 89 88 96 96 70
91 84 88 76 78 88 76 97 99 97 98 99 100 68 80 72 74 74 78 78 102 90 90 86 86
96 98 81 73 64 63 78 98 98 99 99 98 100 75 74 72 72 70 68 68 97 96 98 98 99
96 98 88 81 73 64 68 98 98 98 99 99 100 83 82 81 80 80 72 72 91 86 88 78 80
96 88 89 89 90 95 94 97 97 97 97 97 97 81 80 80 81 82 84 86 98 100 96 90 90
POST - OP - PRIntra OP MAP Intra OP SPO2 POST - OP - MAP
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Sl.No.
24 H 48 H 1 H 2 H 4 H 8 H 12 H 24 H 48 H 1 H 2 H 4 H 12 H 24 H 48 H
78 86 97 98 99 96 98 99 100 1 2 2 6 5 5 3 Fentanyl 2 Doses Nausea + Vomitting +
82 84 99 98 97 99 99 98 99 0 1 2 4 5 6 4 Fentanyl 3 Doses Diclofenc - 1 Dose Nausea + Vomitting +
90 84 98 97 96 95 96 95 96 0 0 1 4 4 4 4 Fentanyl - 4 Doses   Diclofenc - 3 doses Nausea + Vomitting +
98 99 96 96 98 99 96 99 99 1 1 1 5 6 7 5 Fentanyl - 3 Doses         Diclofenac- 2 Doses  Nausea + Vomitting +
92 90 98 99 99 98 97 98 99 0 1 4 4 6 7 4 Fentanyl - 2 Doses         Diclofenac- 1 doses Nausea + Vomitting +
86 90 100 100 99 99 100 100 100 0 1 5 5 6 7 6 Fentanyl - 3 Doses            Diclofenac - 2 Doses  Nausea + 
88 86 100 100 100 100 99 100 100 1 1 5 4 4 8 6 Fentanyl - 3 Doses            Diclofenac - 3 Doses  Vomitting +
92 94 99 98 100 99 100 100 100 0 0 3 2 4 4 4 Fentanyl - 2 Doses            Diclofenac - 2 Doses  -
80 80 97 98 99 100 100 100 100 0 1 1 5 5 6 3 Fentanyl - 1 Dose            Diclofenac - 2 Doses  Nausea + Vomitting +
64 81 99 100 99 100 99 99 98 0 1 1 6 7 5 4 Fentanyl - 1 Doses            Diclofenac - 3 Doses  Nausea + Vomitting +
85 85 100 100 99 99 100 100 100 1 1 1 6 7 7 5 Fentanyl - 2 Doses            Diclofenac - 3 Doses  Nausea + Vomitting +
84 99 96 97 98 99 100 100 100 0 1 1 5 5 7 4 Fentanyl - 2 Doses            Diclofenac - 2 Doses  Nausea + Vomitting +
89 89 96 96 96 99 99 100 100 0 1 1 5 5 6 5 Fentanyl - 2 Doses            Diclofenac - 3 Doses  Nausea + Vomitting +
86 90 100 98 99 99 100 99 98 1 1 1 5 5 7 6 Fentanyl - 3 Doses            Diclofenac - 3 Doses  Nausea + Vomitting +
99 100 97 96 99 99 98 99 100 0 1 1 4 4 6 2 Fentanyl - 1 Dose            Diclofenac - 1 Doses  Nausea + Vomitting +
82 84 100 100 100 98 98 99 100 0 1 1 7 7 7 6 Fentanyl - 3 Doses            Diclofenac - 3 Doses  Nausea + Vomitting +
86 86 98 98 98 98 98 98 98 0 1 1 5 5 8 4 Fentanyl - 1 Dose            Diclofenac - 3 Doses  Nausea + Vomitting +
ORSE
No. of 
Breakthrou
gh Analgeis
No. of rescue analgesia               
F = FENTANYL D-
DICLOSENALC SODIUM
    POST - OP - SPO2 VAS Score
PR MAP SPO2 5m 10m 20 m 30 m 45 m 60 m EOS m
Sl.No. Name of the Patient Age Sex Wt (Kgs) Ht         (cms) BMI ASA Group Diagnosis
Baseline
Duration of 
Technique in 
Seconds
Intra OP PR
18 Jeyapratha 13 F 40 156 16.4 I SS Supracondylar R numerus 87 93 99 539 89 96 99 84 70 77 78
19 Murugan 60 M 52 165 19.1 II SS # Radius Rt Forearm 88 96 99 600 94 80 88 86 90 92 94
20 Valliammal 60 F 52 165 19.1 I SS # R ULNA 82 90 99 630 78 79 86 86 89 90 86
21 Sudalaikannu 45 M 80 170 27.7 I SS Loosed bodies Left Knee 78 95 100 580 68 78 89 99 83 68 78
22 Selvaraj 43 M 75 164 27.9 I SS # R Pronimal Hungavs 90 102 97 495 70 72 68 70 70 89 78
23 Guruswamy 48 M 68 164 25.3 II SS #R Clavicle 89 98 98 500 102 99 98 92 96 95 94
24 Murugan 60 M 52 165 19.1 II SS # ULNA L Side 75 83 99 408 98 99 99 97 86 102 102
25 Murugaraj 70 M 60 169 21 II SS # Supra Condycl R humerus 83 90 98 308 72 72 76 78 86 84 82
26 Muthumurugayee 40 F 70 160 27.3 II SS # 9AlA ZZEI L Side 91 89 99 405 84 84 86 88 86 88 88
27 Arunachalam 25 M 48 164 17.8 I SS # L ULNA 90 96 100 500 98 88 88 86 85 84 78
28 Sivapandian 40 M 70 160 27.3 II SS Supracondycnl # R Femur 86 99 98 500 78 78 76 74 72 70 78
29 Annaraj Peter 43 M 80 170 27.7 II SS # Clavicle R Side 74 90 99 490 79 80 82 84 86 88 89
30 Rajan 34 M 80 172 27 I SS # L UINA 88 87 100 490 65 66 68 72 78 78 78
31 Kumaraswamy 60 M 45 160 17.5 I CS Closed # BB L Forearm 82 96 100 1082 82 80 78 76 80 82 90
32 Sivanpandian 40 M 70 170 24.2 II CS # Olecfa non  R ULNA 82 94 99 1081 82 80 76 77 89 90 96
33 rajan 30 M 56 164 20.8 II CS
Type II Distal 
radius with 
scapnoid
78 97 99 998 78 90 92 78 76 60 78
Sl.No.
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
5m 10m 20 m 30 m 45 m 60 m EOS m 5m 10m 20 m 30 m 45 m 60 m EOS m 1 H 2 H 4 H 8 H 12 H 24 H 48 H 1 H 2 H 4 H 8 H 12 H
POST - OP - PRIntra OP MAP Intra OP SPO2 POST - OP - MAP
96 87 84 79 77 64 69 98 99 99 98 99 96 69 70 72 74 76 78 78 96 88 86 80 78
74 76 87 86 96 90 84 96 95 90 95 95 96 68 66 89 72 86 68 68 74 78 88 88 96
93 86 84 77 79 80 82 97 98 99 100 100 100 100 82 80 80 81 78 78 76 89 90 92 90 92
96 88 81 73 64 78 82 100 100 99 99 100 99 100 80 82 84 86 96 98 84 94 96 96 86 84
98 102 97 90 84 82 77 98 99 99 99 98 99 98 92 90 98 94 94 86 86 100 96 96 89 90
89 102 87 76 69 82 82 97 96 98 98 99 98 99 90 88 88 98 86 88 88 96 99 98 89 86
96 87 84 79 71 79 80 99 98 99 99 99 98 99 74 74 72 70 76 78 78 82 81 82 83 99
97 88 84 76 72 78 88 97 98 98 99 99 99 99 82 84 80 80 82 86 88 99 98 96 94 93
97 96 87 82 77 76 76 99 98 97 99 99 99 99 90 92 92 94 96 96 96 89 88 86 87 88
97 93 87 88 90 94 76 100 100 100 98 99 99 98 90 92 94 94 94 89 88 99 100 102 104 99
98 101 97 90 84 84 90 98 99 99 98 97 96 100 88 86 80 82 84 84 84 96 95 94 96 96
96 97 84 89 76 69 82 100 99 99 99 99 98 99 76 77 79 80 82 84 84 90 90 90 90 92
97 93 87 88 76 76 76 97 97 97 98 99 99 97 89 90 91 92 94 96 98 88 87 86 80 80
97 90 97 86 94 92 90 99 98 97 100 100 97 99 78 79 80 82 84 86 86 90 92 86 88 88
95 93 92 94 90 91 92 100 98 100 99 100 98 100 78 80 78 70 72 68 56 88 90 92 88 86
98 99 86 94 92 90 90 100 99 100 97 97 97 96 82 80 80 96 96 82 83 94 78 78 96 96
Sl.No.
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
24 H 48 H 1 H 2 H 4 H 8 H 12 H 24 H 48 H 1 H 2 H 4 H 12 H 24 H 48 H
ORSE
No. of 
Breakthrou
gh Analgeis
No. of rescue analgesia               
F = FENTANYL D-
DICLOSENALC SODIUM
    POST - OP - SPO2 VAS Score
80 88 99 100 100 96 96 96 98 0 1 1 7 8 7 5 Fentanyl - 2 Doses            Diclofenac - 3 Doses  Nausea + Vomitting +
92 84 100 100 98 98 98 98 99 0 1 1 5 4 5 4 Fentanyl - 2 Doses            Diclofenac - 2 Doses  Nausea + Vomitting +
90 92 99 98 97 96 99 99 99 0 1 1 4 4 6 2 Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
82 82 100 100 100 96 99 96 97 1 1 1 5 5 7 3 Fentanyl - 1 Doses            Diclofenac - 2 Doses  -
92 78 97 100 98 99 98 97 98 0 1 1 7 8 7 3 Fentanyl - 2 Doses            Diclofenac - 2 Doses  -
84 99 98 100 100 100 98 99 99 0 1 1 5 5 6 6 Fentanyl - 3 Doses            Diclofenac - 3 Doses  Nausea +
96 96 99 100 98 99 98 99 98 0 0 1 4 4 5 5 Fentanyl - 3 Doses            Diclofenac - 2 Doses  Nausea + Vomitting +
92 90 98 100 98 99 99 99 99 1 1 1 5 6 7 4 Fentanyl - 2 Doses            Diclofenac - 2 Doses  -
88 88 99 99 99 98 99 98 99 0 1 1 6 7 5 6 Fentanyl - 3 Doses            Diclofenac - 3 Doses  Nausea + Vomitting +
99 99 100 97 96 100 100 100 100 1 1 1 7 7 7 6 Fentanyl - 3 Doses            Diclofenac - 3 Doses  Nausea + Vomitting +
96 96 98 100 100 99 100 99 100 0 1 1 8 7 7 6 Fentanyl - 3 Doses            Diclofenac - 3 Doses  Nausea + Vomitting +
96 96 99 98 99 99 98 99 100 0 1 1 5 5 7 6 Fentanyl - 3 Doses            Diclofenac - 3 Doses  Nausea + Vomitting +
80 90 100 100 100 98 99 100 100 1 1 1 6 7 5 5 Fentanyl - 3 Doses            Diclofenac - 2 Doses  -
90 90 98 99 99 97 98 99 100 1 0 1 2 1 1 1 Fentanyl - 1 Dose            Diclofenac - 1 Dose  Nausea + Vomitting +
90 90 100 97 97 99 96 95 100 0 0 2 2 1 1 0 Diclofenac - 1 Dose  -
91 95 96 96 99 99 99 100 100 1 0 1 1 3 2 1 Diclofenac - 1 Doses  -
PR MAP SPO2 5m 10m 20 m 30 m 45 m 60 m EOS m
Sl.No. Name of the Patient Age Sex Wt (Kgs) Ht         (cms) BMI ASA Group Diagnosis
Baseline
Duration of 
Technique in 
Seconds
Intra OP PR
34 Sivathiammal 45 F 65 160 25.4 II CS
OLP Monteggia # 
Dislocations  L 
Side
98 86 100 1290 98 100 102 98 97 99 100
35 Budhyaraj 37 M 68 158 27.2 I CS
Chronic 
Osteomyelitis @ 
Humerus
70 94 100 1300 70 72 68 74 76 77 78
36 Shanmugakutti 45 M 60 158 24 II CS
Closed # 
Intercondynl 
Humerus
76 94 100 890 76 90 94 88 86 85 83
37 Rajasekar 15 M 30 155 12.5 I CS Closed # L ULNA 82 96 100 990 82 81 80 78 76 77 80
38 Mohamed Ali 65 M 50 160 19.5 II CS Malunited Distal radius 100 96 100 1350 100 99 78 78 80 80 86
39 Mathi Parthiban 16 M 45 150 20 II CS 3 part # proximal R humerus 98 86 100 998 98 102 104 99 86 90 92
40 Senthil Nayagam 58 M 68 164 25.3 II CS # shaft of UINA 100 97 99 1020 100 101 99 98 89 99 91
41 Ganapathy 60 M 75 170 25.8 II CS # Shaft of Humerus 98 98 99 998 98 88 76 96 95 94 92
42 Jayalakshmi 18 F 50 155 20.8 II CS Postcubitus Varaus Correction 87 78 100 1020 87 86 85 84 82 80 80
43 Mayil Swamy 60 M 60 158 24 I CS
Old Neglected & 
dislocation of 
Elbow
86 97 97 900 85 84 80 84 89 90 78
44 Muthurkrishnan N 45 M 50 160 19.5 I CS # Dislocation R Shoulder 97 86 98 1002 96 90 78 80 88 86 88
45 Cherman 55 M 52 165 19.1 I CS Communited # M/2 R Clavicle 80 88 99 990 79 80 82 80 82 80 86
46 Ayyadurai 50 M 80 170 27.7 II CS # 4th Meta Carpal 68 84 100 880 69 72 74 78 82 86 84
47 Ramkumar 50 M 80 172 27 II CS # L ULNA 62 78 100 1400 60 62 68 72 76 86 80
48 Maria Selvam 55 F 75 164 27.9 II CS Implant riaws with BB R forearm 75 90 99 1380 74 72 86 88 90 84 80
49 Krishnan 29 M 78 172 26.4 II CS # Right Clavicle 89 82 100 1400 89 80 88 84 2 88 86
Sl.No.
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
5m 10m 20 m 30 m 45 m 60 m EOS m 5m 10m 20 m 30 m 45 m 60 m EOS m 1 H 2 H 4 H 8 H 12 H 24 H 48 H 1 H 2 H 4 H 8 H 12 H
POST - OP - PRIntra OP MAP Intra OP SPO2 POST - OP - MAP
87 80 84 82 80 81 82 99 100 100 97 99 100 100 87 88 90 92 94 96 98 92 91 99 86 84
95 94 90 92 93 90 94 100 87 97 98 99 100 100 98 100 100 96 88 84 84 90 80 81 86 96
95 94 90 92 92 92 91 100 97 98 99 100 100 100 100 98 96 94 92 90 92 68 96 94 93 92
96 98 98 99 96 94 92 100 97 100 100 99 100 99 86 88 88 89 88 89 90 75 86 86 84 83
99 98 94 96 99 99 96 99 98 99 10 98 99 100 88 90 86 84 82 82 82 80 78 76 96 88
89 88 89 90 92 94 96 99 100 100 96 95 96 96 89 90 91 94 94 92 82 84 84 83 92 84
98 99 96 96 89 89 99 99 100 96 89 90 94 99 90 92 92 94 94 94 90 86 78 78 68 86
99 98 97 100 89 86 98 100 99 96 95 95 95 96 78 80 82 82 84 84 86 88 80 81 86 96
9 97 96 94 94 94 98 99 89 89 90 91 92 99 77 80 82 84 86 88 90 89 90 90 88 78
97 96 94 92 97 86 86 99 99 100 98 97 100 97 92 94 99 100 86 88 82 86 80 82 80 78
80 78 80 82 84 86 88 98 100 99 98 97 100 100 74 78 82 82 82 72 79 88 80 82 84 78
82 80 82 84 86 90 80 99 98 97 97 98 99 100 80 94 76 86 82 78 78 80 80 80 86 84
84 86 82 80 78 80 82 100 97 98 99 100 98 97 76 70 72 74 74 78 72 82 78 76 82 80
80 78 78 82 84 84 84 100 98 98 98 98 97 99 80 82 81 72 90 92 94 84 81 82 96 88
88 86 80 88 86 82 82 100 100 97 98 100 97 97 72 70 78 82 73 84 84 82 80 82 82 78
80 78 80 72 88 80 80 99 98 100 98 100 97 99 91 82 82 80 78 78 80 80 76 74 82 84
Sl.No.
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
24 H 48 H 1 H 2 H 4 H 8 H 12 H 24 H 48 H 1 H 2 H 4 H 12 H 24 H 48 H
ORSE
No. of 
Breakthrou
gh Analgeis
No. of rescue analgesia               
F = FENTANYL D-
DICLOSENALC SODIUM
    POST - OP - SPO2 VAS Score
83 82 99 100 100 100 99 100 97 0 1 1 1 1 0 1 Diclofenac - 1 Doses  -
96 98 98 99 100 100 98 99 100 0 0 2 1 1 1 0 - -
91 90 97 96 95 94 96 96 96 1 1 1 1 0 1 0 Diclofenac - 1 Dose  -
82 81 100 100 98 98 98 98 98 0 1 1 1 1 1 1 Diclofenac - 1 Dose  -
82 84 99 100 98 98 98 98 98 0 1 1 2 1 1 1 Diclofenac - 1 Dose  -
83 81 100 100 100 100 98 100 99 0 0 1 3 1 1 0 - -
85 74 99 97 100 97 100 97 98 1 1 1 1 2 1 2 Fentanyl - 1 Doses            Diclofenac - 1 Doses  Nausea + Vomitting +
86 86 99 99 97 98 99 97 98 0 1 1 1 1 1 1 Diclofenac - 1 Doses  -
78 78 98 99 99 99 99 98 100 0 1 1 1 1 1 1 - -
76 76 98 100 99 100 100 98 100 1 0 1 3 2 2 Fentanyl - 1 Doses            Diclofenac - 1 Doses  Nausea + Vomitting +
74 72 98 100 100 97 100 100 100 1 0 1 2 1 2 Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
82 80 100 98 97 100 100 97 100 1 0 1 1 1 - Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
80 80 100 98 96 100 100 100 1 1 1 0 1 - Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
86 84 97 100 100 98 98 100 100 0 1 1 1 0 - Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
76 74 99 100 97 100 98 100 100 1 1 3 2 1 2 Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
86 88 99 100 100 97 100 99 100 1 1 1 0 1 *- Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
PR MAP SPO2 5m 10m 20 m 30 m 45 m 60 m EOS m
Sl.No. Name of the Patient Age Sex Wt (Kgs) Ht         (cms) BMI ASA Group Diagnosis
Baseline
Duration of 
Technique in 
Seconds
Intra OP PR
50 Submranian 62 M 45 160 17.6 II CS I Rhumerus # RUINA 88 84 100 990 86 84 90 78 94 96 78
51 Sudalaiyandi 39 M 69 166 25 I CS # R Clavicle 62 78 98 880 60 82 86 84 93 98 102
52 Saravanan 25 M 74 164 27.9 II CS Old # Olecranon Rt ULNA 94 88 100 1100 92 82 84 86 92 99 100
53 Kajah Mydeen 29 M 78 160 25 I CS # Left Patella 94 88 100 1200 94 92 86 80 86 80 94
54 Ramesh I 29 M 78 160 25 I CS Compound # BB M/3 L LFS 78 82 100 998 72 70 76 78 70 80 86
55 Venkiah 70 M 60 169 21 I CS # BS Rt Leg Distal 88 86 100 1100 88 90 92 94 86 82 80
56 Rajeswaran 48 M 52 165 19.1 II CS # R Scaphoid 92 78 99 1300 92 90 86 88 84 82 86
57 Parvathy 60 F 60 169 21 II CS Osteomyalitai R ULNA 90 92 100 1450 90 92 94 96 92 92 90
58 Susila Mary 35 F 69 166 25 II CS Old # Ulna D/3 implant insita 86 80 100 1220 86 88 86 87 88 88 90
59 Erulan 35 M 70 160 27.3 II CS Malunited # Shaft of L humerus 72 78 99 990 72 70 86 88 84 82 84
60 Madathi 31 F 48 164 17.8 II CS Old unreduced Elbow dislocation 80 84 100 1100 80 78 80 82 82 82 80
Sl.No.
50
51
52
53
54
55
56
57
58
59
60
5m 10m 20 m 30 m 45 m 60 m EOS m 5m 10m 20 m 30 m 45 m 60 m EOS m 1 H 2 H 4 H 8 H 12 H 24 H 48 H 1 H 2 H 4 H 8 H 12 H
POST - OP - PRIntra OP MAP Intra OP SPO2 POST - OP - MAP
82 78 76 74 84 82 82 100 97 98 98 98 98 97 86 80 90 86 92 92 92 82 80 82 82 80
80 82 84 84 86 88 88 100 98 98 100 99 100 100 74 72 70 88 90 92 92 88 80 82 84 86
86 85 84 82 83 81 81 98 100 99 97 100 97 97 86 80 86 80 82 88 88 81 80 82 82 82
88 90 92 94 96 82 82 100 97 98 99 100 99 100 100 110 98 99 100 91 98 82 92 78 74 72
83 82 89 92 78 76 80 98 99 100 98 99 100 100 76 76 80 72 70 82 82 82 80 80 84 86
88 90 88 92 78 74 80 98 99 100 100 88 99 100 86 80 78 76 74 84 84 86 84 80 82 86
92 94 90 88 86 90 92 98 100 100 100 98 100 100 90 88 86 84 82 86 88 78 79 82 84 86
80 84 90 88 86 88 84 98 100 99 100 100 100 100 88 86 80 78 80 88 90 92 90 86 85 84
78 80 84 86 88 90 92 97 98 99 100 100 100 98 84 80 86 82 80 86 88 80 82 84 86 88
84 82 80 78 80 80 80 97 98 97 98 97 98 100 70 72 70 68 72 74 76 78 80 82 84 76
90 88 78 80 82 86 100 100 100 100 98 99 100 82 80 78 76 78 80 82 84 80 83 86 80
Sl.No.
50
51
52
53
54
55
56
57
58
59
60
24 H 48 H 1 H 2 H 4 H 8 H 12 H 24 H 48 H 1 H 2 H 4 H 12 H 24 H 48 H
ORSE
No. of 
Breakthrou
gh Analgeis
No. of rescue analgesia               
F = FENTANYL D-
DICLOSENALC SODIUM
    POST - OP - SPO2 VAS Score
78 98 100 98 98 97 97 100 100 1 1 1 0 1 - Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
86 86 100 99 100 98 98 100 100 1 1 0 1 1 - Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
80 80 100 97 99 100 100 97 100 1 1 0 1 1 - Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
84 82 100 97 98 98 98 100 100 1 1 0 1 1 - Fentanyl - 1 Doses            Diclofenac - 1 Doses  Nausea + Vomitting +
88 90 100 99 100 99 99 100 99 1 0 1 1 1 1 - Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
88 86 100 100 100 100 100 100 100 0 1 0 1 1 1 - Fentanyl - 1 Doses            Diclofenac - 1 Doses  -
82 80 99 100 100 98 100 99 100 1 1 1 0 1 1 - Nil -
82 80 100 100 100 98 100 100 96 1 1 0 1 1 1 1 Nil -
86 86 99 98 97 98 98 98 98 0 0 1 1 1 1 - Nil -
80 82 100 98 97 97 98 99 100 0 1 1 1 1 1 - Nil -
82 80 100 100 100 99 100 99 100 1 1 1 0 0 0 - Nil -
